首页 | 本学科首页   官方微博 | 高级检索  
检索        

Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia
引用本文:蔡志友,晏勇,晏宁,王凤英,黄华,王咏龙,赵宇.Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia[J].中国人民解放军军医大学学报,2007,22(6):352-356.
作者姓名:蔡志友  晏勇  晏宁  王凤英  黄华  王咏龙  赵宇
作者单位:[1]Department of Neurology, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016,China [2]Department of Neurology, First Affiliated Hospital, Zunyi Medical College, Guizhou 563003, China
摘    要:Objective:To investigate serum levels of MMP-2,MMP-9, oxidized low-density lipoprotein (ox-LDL) in Alzheimer's disease (AD) patients and study the possible pathway and mechanism of AD with abnormal lipid metabolism. Methods: Subjects in this study were divided into 4 groups : normal lipid group without AD (N), hyperlipoidemia group without AD (H), normal group with AD (A), hyper- lipoidemia group with AD (AH). There were 15 individuals in each group. MMP-2, MMP-9, ox-LDL was measured by enzyme linked immunosorbent assay (EL1SA). Serum lipids levels were measured by biochemical methods. Results: The serum levels of MMP-2, MMP-9, ox-LDL were significantly higher in H, A and AH groups than those in N group. Those of ox-LDL in H, AH groups was higher than that of in A group. The serum level of MMP-2, MMP-9 in AH groups were higher than that of in H group. The score of mini-mental state examination (MMSE) in A and AD groups was negatively correlated with the serum level of ox-LDL. Relationship between the score of MMSE and the serum level of ox-LDL in AD groups and non-AD groups had statistical significance. Conclusion: MMP-2, MMP-9, ox-LDL and abnor- mal lipid metabolism may participate in pathogenesis of AD, in which abnormal lipid metabolism induces expressions of MMP-2,MMP-9 and ox-LDL. Oxidative stress and blood-brain barrier disruption might ac- celerate the process of AD.

关 键 词:阿耳茨海默氏病  早老性痴呆  高脂血  血清检测
收稿时间:2007-06-11
修稿时间:2007-11-29

Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia
CAI Zhi-you,YAN Yong,YAN Ling,WANG Feng-ying,HUANG Hua,WANG Yong-long,ZHAO Yu.Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer''''s disease with hyperlipoidemia[J].Journal of Medical Colleges of PLA(China),2007,22(6):352-356.
Authors:CAI Zhi-you  YAN Yong  YAN Ling  WANG Feng-ying  HUANG Hua  WANG Yong-long  ZHAO Yu
Institution:2. Department of Neurology, Universitair Ziekenhuis Brussel, Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Belgium;3. Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;2. Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark;1. Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University, China;2. School of Mathmatics and Computational Science, Sun Yat-sen University, China;3. Department of Neurology, Second Affiliated Hospital of GuangZhou Medical University, China;4. Department of clinical laboratory, Third Affiliated Hospital of Sun Yat-sen University, China;5. Department of Neurology, Fifth Affiliated Hospital of Sun Yat-sen University, China;1. Department of Neurology, Shanghai Ninth People''s Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shangaï, China;2. Pôle Information Médicale Evaluation Recherche Hospices Civils de Lyon, Lyon, France and Université Lyon 1 et Equipe d''Accueil 4129 Lyon, France;3. Cerebrovascular Unit, Department of Neurology, Université Claude Bernard, Lyon, France;4. Laboratoire d''hématologie, CBPE, Hospices Civils de Lyon, Lyon, France
Abstract:ObjectiveTo investigate serum levels of MMP-2,MMP-9, oxidized low density lipoprotein (ox-LDL) in Alzheimer's disease (AD) patients and study the possible pathway and mechanism of AD with abnormal lipid metabolism. Methods Subjects in this study were divided into 4 groups normal lipid group without AD (N), hyperlipoidemia group without AD (H), normal group with AD (A), hyperlipoidemia group with AD (AH). There were 15 individuals in each group. MMP-2, MMP-9, ox-LDL was measured by enzyme linked immunosorbent assay (ELISA). Serum lipids levels were measured by biochemical methods. Results The serum levels of MMP-2, MMP-9, ox-LDL were significantly higher in H, A and AH groups than those in N group. Those of ox LDL in H, AH groups was higher than that of in A group. The serum level of MMP-2, MMP-9 in AH groups were higher than that of in H group. The score of mini-mental state examination (MMSE) in A and AD groups was negatively correlated with the serum level of ox-LDL. Relationship between the score of MMSE and the serum level of ox-LDL in AD groups and non-AD groups had statistical significance. Conclusion MMP-2, MMP-9, ox-LDL and abnormal lipid metabolism may participate in pathogenesis of AD, in which abnormal lipid metabolism induces expressions of MMP-2,MMP-9 and ox-LDL. Oxidative stress and blood-brain barrier disruption might accelerate the process of AD.
Keywords:Alzheimer's disease  matrix metalloproteinase  blood-brain barrier  lipid metabolism
本文献已被 维普 万方数据 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号